El interés en corto de Nurix Therapeutics da a los inversores una idea del grado en que los inversores apuestan por la caída de las acciones de Nurix Therapeutics. Los datos de interés en corto se actualizan cada dos semanas.

Nurix Therapeutics (NASDAQ:NRIX) Bolsa, Informe de interés en corto

NURIX THERAPEUTICS INC

Nurix Therapeutics

Nurix Therapeutics Inc is a biopharmaceutical company focused on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders. The company's pipeline comprises targeted protein degraders of Brutons tyrosine kinase, or BTK, a B-cell signaling protein, and inhibitors of Casitas B-lineage lymphoma proto-oncogene-B, or CBL-B, an E3 ligase that regulates T cell activation. Its drug candidate from protein degradation portfolio, NX-2127, is an orally available BTK degrader for the treatment of relapsed or refractory B-cell malignancies.

Trading Ideas

BRNS

Barinthus Biotherapeutics Shares Resume Trade

Barinthus Biotherapeutics Shares Halted On Circuit Breaker To The Upside, Stock Now Up 92.2%

Macro Economic Events

News

Politics

Global

Economics

General

Reuters Reports Brazil's Government Sent Letter About Tariffs To U.S. Officials On July 15; Brazil Expressed Indignation At U.S. Announcement Of 50% Tariff On Brazil Goods; Says It Remains Ready To Engage In Dialogue With U.S. Authorities, Negotiate Mutually Acceptable Solution On Trade

Citigroup analyst James Hardiman maintains Royal Caribbean Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RCL#NYSE">RCL</a>) with a Buy and raises the price target from $318 to $390.

Price Target

Analyst Ratings

Citigroup Maintains Buy on Royal Caribbean Gr, Raises Price Target to $390

Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) surged to <a href="https://www.benzinga.com/markets/25/07/46404410/bitcoin-shatters-all-time-high-to-hit-123-000-as-ethereum-cracks-3-000-and-xrp-taps-3">new all-time highs</a> last week, and a new poll now gauges whether it will retreat to $100,000 or rally toward $150,000 next.
What Happened: Bitcoin reached an all-time high of $123,091.61 on July 14. The milestone underscored the optimism felt by investors ahead of what Congress members dubbed "Crypto Week,&#8221; in which <a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46424764/trump-wishes-bitcoin-ethereum-xrp-happy-crypto-week-it-is-all-part-of-make-america-great-again">several cryptocurrency-related bills</a> are up for vote.
Bitcoin pulled back on Tuesday as the bills failed to gain traction in Congress, but it remains ahead of levels seen last week.
Benzinga recently polled its users on social media to ask where Bitcoin could trade next.
"With Bitcoin at record highs, what's the more likely move from here?" Benzinga asked on <a href="https://www.instagram.com/benzinga/?hl=en">its Instagram page.</a>
The results were:
<ul class="wp-block-list">
<li>Pulls back to $100,000: 47%</li>
<li>Breaks out to $150,000: 53%</li>
</ul>
The poll found that a slim majority believe Bitcoin could continue to set new all-time highs and hit the $150,000 milestone first before returning to $100,000 or under six figures.
Benzinga also polled its users on Threads with the same question:
<ul class="wp-block-list">
<li>Pulls back to $100,000: 54%</li>
<li>Breaks out to $150,000: 46%</li>
</ul>
That poll, which had significantly fewer responses than the Instagram poll, saw respondents take the other side of the options. A pullback to the $100,000 level won the poll with 54% of the vote.
Read Also: <a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46441190/600m-in-1-day-why-are-bitcoin-ethereum-etf-suddenly-so-bullish">$600M In 1 Day: Why Are Bitcoin, Ethereum ETF Suddenly So Bullish?</a>
Why It's Important: The contrasting results of the polls and slim majorities could indicate that investors are divided on what will happen to Bitcoin in the second half of 2025.
This follows <a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/46053846/will-bitcoin-hit-new-all-time-highs-after-dip-under-100k-heres-what-new-poll-predicts">a June poll </a>conducted by Benzinga asking if Bitcoin would hit new all-time highs after its dip under $100,000 or would head back to the five-figure range. At the time with Bitcoin trading at $107,500, the poll was split 50%, 50%.
The price of Bitcoin would later hit new all-time highs and has yet to go below the $100,000 level since the poll was conducted.
Another&nbsp;<a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/45871245/exclusive-bitcoin-to-hit-200k-in-2025-15-say-yes-while-many-see-new-all-time-highs-coming" target="_blank" rel="noreferrer noopener">recent Benzinga poll in May&nbsp;</a>asked readers to predict the highest price Bitcoin will hit before the end of the year.
&#8220;Bitcoin hit new all-time highs of nearly $112,000 in May 2025. Do you believe this will be the top price for BTC in 2025 or will the leading cryptocurrency hit new highs later this year?" Benzinga asked.
The results were:
<ul class="wp-block-list">
<li>Bitcoin will hit $112K to $130K: 32%</li>
<li>Bitcoin will hit $130K to $150K: 24%</li>
<li>Bitcoin will hit $150K to $200K: 15%</li>
<li>Bitcoin will hit $200K+: 15%</li>
<li>Bitcoin has already topped at $112K: 14%</li>
</ul>
The 14% who predicted that Bitcoin had already topped in 2025 ended up being wrong. So far, the top answer of the $112K to $130K range are right. Time will tell if Bitcoin can hit one of the higher ranges before the end of the year.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46400732/if-you-invested-1000-in-bitcoin-when-donald-trump-said-cryptos-value-was-based-on-thin-air-heres-how-much-youd-have-now">If You Invested $1,000 In Bitcoin When Donald Trump Said Crypto&#8217;s Value Was &#8216;Based On Thin Air,&#8217; Here&#8217;s How Much You&#8217;d Have Now</a></li>
</ul>
The study was conducted by Benzinga from July 14, 2025, through July 16, 2025. It included the responses of a diverse population of social media followers. Opting into the survey was completely voluntary, with no incentives offered to potential respondents. The study reflects results from 3,470 people on Instagram and 89 people on Threads.
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Exclusives

Markets

$BTC

Will Bitcoin Hit $150K Before Retesting $100K? This Answer Narrowly Wins New Poll

Keybanc analyst Jason Celino maintains FirstEnergy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FE#NYSE">FE</a>) with a Overweight and lowers the price target from $47 to $46.

Keybanc Maintains Overweight on FirstEnergy, Lowers Price Target to $46

<a href="https://scr.zacks.com/files/News/2025/Zacks_SCR_Research_07162025_ENSC_Sorensen.pdf" title="https://scr.zacks.com/files/News/2025/Zacks_SCR_Research_07162025_ENSC_Sorensen.pdf">https://scr.zacks.com/files/News/2025/Zacks_SCR_Research_07162025_ENSC_Sorensen.pdf</a>

ENSC

Watching Ensysce Biosciences; Zacks Small-Cap Research Reiterates $18.45 Price Valuation; Was Originally Given On May 14, 2025

Citigroup analyst James Hardiman maintains Viking Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VIK#NYSE">VIK</a>) with a Buy and raises the price target from $57 to $68.

Citigroup Maintains Buy on Viking Holdings, Raises Price Target to $68

Offerings

MNDR

Mobile-Health Network Solutions Files For Mixed Shelf Of Up To $300M

Keybanc analyst Jackson Ader maintains Exelon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXC#NASDAQ">EXC</a>) with a Underweight and lowers the price target from $39 to $37.

Keybanc Maintains Underweight on Exelon, Lowers Price Target to $37

<a href="https://www.semafor.com/article/07/16/2025/amazon-launches-ai-agent-building-platform-for-businesses-to-help-boost-productivity" title="https://www.semafor.com/article/07/16/2025/amazon-launches-ai-agent-building-platform-for-businesses-to-help-boost-productivity">https://www.semafor.com/article/07/16/2025/amazon-launches-ai-agent-building-platform-for-businesses-to-help-boost-productivity</a>

AMZN

'Amazon Launches AI Agent-Building Platform For Businesses To Help Boost Productivity' - Semafor

<a href="https://www.bloomberg.com/news/articles/2025-07-16/swiss-trade-deal-with-us-is-awaiting-trump-s-sign-off-bern-says?embedded-checkout=true">https://www.bloomberg.com/news/articles/2025-07-16/swiss-trade-deal-with-us-is-awaiting-trump-s-sign-off-bern-says?embedded-checkout=true</a>

'Swiss Trade Deal With US Is Awaiting Trump's Sign Off, Bern Says'- Bloomberg

<a href="https://www.politico.com/live-updates/2025/07/16/congress/trio-of-crypto-bills-back-on-track-scalise-says-00455766" title="https://www.politico.com/live-updates/2025/07/16/congress/trio-of-crypto-bills-back-on-track-scalise-says-00455766">https://www.politico.com/live-updates/2025/07/16/congress/trio-of-crypto-bills-back-on-track-scalise-says-00455766</a>

Legal

$ETH

'Trio Of Crypto Bills Back On Track, Scalise Says' - Politico

Keybanc analyst Jackson Ader maintains Entergy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ETR#NYSE">ETR</a>) with a Overweight and raises the price target from $85 to $88.

Keybanc Maintains Overweight on Entergy, Raises Price Target to $88

Citigroup analyst James Hardiman maintains Norwegian Cruise Line (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NCLH#NYSE">NCLH</a>) with a Buy and raises the price target from $25 to $30.

NCLH

Citigroup Maintains Buy on Norwegian Cruise Line, Raises Price Target to $30

<a href="https://www.washingtonpost.com/health/2025/07/16/psychedelics-rfk-jr-kennedy-ibogaine-mdma/41658b06-6246-11f0-bf70-56d8888ebb94_story.html" title="https://www.washingtonpost.com/health/2025/07/16/psychedelics-rfk-jr-kennedy-ibogaine-mdma/41658b06-6246-11f0-bf70-56d8888ebb94_story.html">https://www.washingtonpost.com/health/2025/07/16/psychedelics-rfk-jr-kennedy-ibogaine-mdma/41658b06-6246-11f0-bf70-56d8888ebb94_story.html</a>

Biotech

CMPS

CYBN

DRUG

ENVB

MNMD

'RFK Jr. and other Trump officials embrace psychedelics after FDA setback' - Washington Post

Metropolitan Bank Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCB#NYSE">MCB</a>) is preparing to release its quarterly earnings on Thursday, 2025-07-17. Here's a brief overview of what investors should keep in mind before the announcement.
Analysts expect Metropolitan Bank Holding to report an earnings per share (EPS) of $1.69.
Investors in Metropolitan Bank Holding are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
<h3>Earnings History Snapshot</h3>
During the last quarter, the company reported an EPS missed by $0.08, leading to a 3.6% increase in the share price on the subsequent day.
Here's a look at Metropolitan Bank Holding's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q1 2025</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>1.53</td>
<td>1.49</td>
<td>1.55</td>
<td>1.57</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>1.45</td>
<td>1.88</td>
<td>1.86</td>
<td>1.50</td>
</tr>
<tr>
<td>Price Change %</td>
<td>4.0%</td>
<td>8.0%</td>
<td>-7.000000000000001%</td>
<td>3.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1752678151_0.png" alt="eps graph" />
<h3>Tracking Metropolitan Bank Holding's Stock Performance</h3>
Shares of Metropolitan Bank Holding were trading at $73.26 as of July 15. Over the last 52-week period, shares are up 37.32%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<a href="https://www.benzinga.com/quote/MCB/earnings">To track all earnings releases for Metropolitan Bank Holding visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings

Uncovering Potential: Metropolitan Bank Holding's Earnings Preview

TROOPS, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TROO#NASDAQ">TROO</a>) ("TROOPS" or the "Company") today announced that its wholly-owned subsidiary, Giant Connection Limited (the "Purchaser"), has entered into a Letter of Intent ("LOI") with Jupiter Stone Holding Limited (the "Vendor") to acquire a 49% equity interest in Y Concept Holding Limited, the Hong Kong parent company of The Cara Hotel, a co-living and co-working space in Malaysia.
Key Transaction Details
<ul>
<li>Acquisition Structure: Giant Connection Limited will acquire 49% of Jupiter Stone Holding Limited's 62.5% ownership in Y Concept Holding Limited. The&nbsp;LOI includes a put option for the Vendor to sell the remaining 51% at a later date.</li>
<li>Payment Terms: The transaction will be settled through convertible notes issued by TROOPS, valued at 80% of the lower of (i) the closing share price on the date of signing or (ii) the average closing share price over the prior 60 trading days.</li>
<li>Repurchase Option: TROOPS retains the right to repurchase the consideration shares at the prevailing market price.</li>
<li>Strategic Objective: This acquisition strengthens TROOPS' business portfolio by expanding its presence in Malaysian co-living and co-working space.</li>
</ul>
Conditions Precedent
The transaction is subject to the following conditions:
<ul>
<li>Satisfactory completion of financial and legal due diligence.</li>
<li>Obtaining necessary regulatory approvals, including from&nbsp;NASDAQ and the U.S. Securities and Exchange Commission (SEC).</li>
<li>Approval by the boards of directors of both parties.</li>
<li>No material adverse changes in Y Concept Holding Limited's business operations or financial conditions.</li>
</ul>
Strategic Significance
This acquisition aligns with TROOPS' strategy to diversify its investments and capitalize on the robust growth in Asia's flexible living and working space sector. The Cara Hotel is well-positioned to benefit from increasing demand for co-living and co-working space in Malaysia.
Next Steps
Due diligence is in progress, with definitive agreements expected to be finalized upon satisfaction of all conditions precedent.&nbsp;

TROO

TROOPS' Giant Connection Enters Into LOI With Jupiter Stone Holding To Acquire 49% Equity Interest In Y Concept Holding

Bank7 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BSVN#NASDAQ">BSVN</a>) will release its quarterly earnings report on Thursday, 2025-07-17. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate Bank7 to report an earnings per share (EPS) of $0.99.
Anticipation surrounds Bank7's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
<h3>Historical Earnings Performance</h3>
The company's EPS beat by $0.09 in the last quarter, leading to a 2.32% drop in the share price on the following day.
Here's a look at Bank7's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q1 2025</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.99</td>
<td>1.05</td>
<td>1.07</td>
<td>1.04</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>1.08</td>
<td>1.16</td>
<td>1.24</td>
<td>1.23</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-2.0%</td>
<td>-0.0%</td>
<td>7.000000000000001%</td>
<td>5.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1752678138_0.png" alt="eps graph" />
<h3>Tracking Bank7's Stock Performance</h3>
Shares of Bank7 were trading at $45.55 as of July 15. Over the last 52-week period, shares are up 25.66%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<a href="https://www.benzinga.com/quote/BSVN/earnings">To track all earnings releases for Bank7 visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BSVN

What to Expect from Bank7's Earnings

Western Alliance (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WAL#NYSE">WAL</a>) is set to give its latest quarterly earnings report on Thursday, 2025-07-17. Here's what investors need to know before the announcement.
Analysts estimate that Western Alliance will report an earnings per share (EPS) of $2.02. 
The market awaits Western Alliance's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
<h3>Earnings Track Record</h3>
In the previous earnings release, the company beat EPS by $0.01, leading to a 0.71% increase in the share price the following trading session.
Here's a look at Western Alliance's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q1 2025</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>1.78</td>
<td>1.92</td>
<td>1.89</td>
<td>1.70</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>1.79</td>
<td>1.95</td>
<td>1.80</td>
<td>1.75</td>
</tr>
<tr>
<td>Price Change %</td>
<td>1.0%</td>
<td>-5.0%</td>
<td>-9.0%</td>
<td>8.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1752678125_0.png" alt="eps graph" />
<h3>Market Performance of Western Alliance's Stock</h3>
Shares of Western Alliance were trading at $80.99 as of July 15. Over the last 52-week period, shares are up 14.72%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<a href="https://www.benzinga.com/quote/WAL/earnings">To track all earnings releases for Western Alliance visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

A Preview Of Western Alliance's Earnings

Health Care

Press Releases

Nurix Therapeutics Announces Presentations of Clinical Data at the 30th European Hematology Association Congress and the 18th International Conference on Malignant Lymphoma

Nurix Therapeutics to Participate in the RBC Capital Markets Global Healthcare Conference

Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Nurix Therapeutics to Participate in the Jefferies Global Healthcare Conference

Sanofi Exercises License Extension Option to Nurix's STAT6 Program

Nurix Therapeutics to Host a Webcast Conference Call to Discuss Data from the Ongoing Phase 1 Clinical Trial of Bexobrutideg (NX-5948) Being Presented at the 30th European Hematology Association Congress (EHA2025)

Nurix Therapeutics Presents Updated Positive Data Demonstrating Durable, Deepening Responses in Ongoing Clinical Trial of Bexobrutideg (NX-5948) Monotherapy in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) and Waldenström Macroglobulinemia (WM)

European Medicines Agency Grants Bexobrutideg (NX-5948) Orphan Drug Designation for the Treatment of Lymphoplasmacytic Lymphoma, also Known as Waldenström Macroglobulinemia

Comments

Nurix Therapeutics

Interés en corto

Nurix Therapeutics (NASDAQ:NRIX) Bolsa, Informe de interés en corto

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL